Hear how experienced physicians approach real cases
BackTable is the podcast-based learning platform for specialized healthcare providers. Get practical advice from your peers in the field.
Weekly conversations from leading voices in your specialty.
Vascular & IR
For interventional radiologists, vascular surgeons, and interventional cardiologists.
ENT & Allergy
For otolaryngologists, head and neck surgeons, and allergists.
Urology
For urologists, urologic oncologists, and urogynecologists.
Curbsiders
For internal medicine, primary care, family medicine, and hospitalists.
Cardiology
For medical cardiologists, cardiac surgeons, and interventional cardiologists.
CardioNerds
For anyone interested in the prevention and management of cardiovascular disease.
CathMasters
For practical interventional cardiology education.
Tumor Board
For medical oncologist, surgical oncologists, and radiation oncologists.
Women's Health
For OBGYNs, gynecologic surgeons, and women's health specialists.
Bone & Sports
For orthopedic surgeons, sports medicine docs, pain specialists, and MSK radiologists.
Litigation
For physicians navigating the complex world of medical malpractice lawsuits.
Industry
For healthcare leaders, business-minded providers, and innovators.
Podcasts
- Tumor Board # 88Oct 30, 2026
Beyond First-Line Therapy: Treatment Strategies for Advanced Neuroendocrine Tumors
Few oncologists know neuroendocrine tumors from both sides of the exam table: first as a patient diagnosed during training, and now as the doctor treating them. This physician brings both perspectives to one pressing question: when a tumor progresses on a somatostatin analog, what comes next? On this episode of BackTable Tumor Board, Dr. Aman Chauhan, a medical oncologist at UCSF, interviews Dr. Mark Lewis, director of gastrointestinal oncology at Intermountain Health in Salt Lake City, about treatment strategies for advanced neuroendocrine tumors beyond first-line therapy. They start with what progression on a somatostatin analog really means, how grade, Ki-67, primary site, and the pace of liver disease shape the next step, and why observation is sometimes the right call. Dr. Lewis explains how he sets expectations for PRRT after NETTER-1 and NETTER-2, including the small but real risk of secondary myelodysplasia and leukemia.
- Vascular & IR # 688Oct 30, 2026
Gallbladder Cryoablation: Technique & Clinical Insights
How can whole-gallbladder cryoablation reshape care and quality of life for patients dependent on chronic cholecystostomy tube management? In this episode of the BackTable Podcast, interventional radiologist Dr. DaeHee Kim (Brown University Health) joins guest host Dr. Jessica Yoon (Ohio State University) to explore how percutaneous gallbladder cryoablation could offer a definitive option for patients who cannot have surgery and might otherwise live with a cholecystostomy tube for years. They cover how he has selected patients to build a referral pathway with general surgery, how he performs the procedure, and what he has learned from his early experience.
- Urology # 339Oct 29, 2026
AI's Role in Enhancing Urology Care
By his own estimate, an AI scribe gives one urologist about two hours of his day back, and an evidence tool built into it has taught him something new in the clinic almost every day. On this episode of BackTable Urology, Dr. Ruchika Talwar welcomes back Dr. David Canes, urologist at Lahey Hospital & Medical Center and founder of WellPrept, to talk about how urologists can practically put AI to work. Dr. Canes explains why he sees this moment as a renaissance for physicians, how an AI scribe turned him from author into proofreader, by his estimate saving about two hours a day, and why evidence tools running alongside the scribe now answer questions in the exam room, including a question about post-prostatectomy dysorgasmia, a complaint that rarely comes up in clinic.
- Women's Health # 137Oct 27, 2026
Obesity Medicine in Women’s Health
Heart disease is still the leading cause of death in women, and for many women the OBGYN is the only doctor they see each year, so how can obesity medicine become a natural part of that visit? On this episode of BackTable Women’s Health, Dr. Nicole Faulkner is joined by Dr. Taylor Hahn, an OBGYN board certified in obesity medicine and founder of VIA Women’s Health Collective, to discuss how general OBGYNs can integrate obesity care into everyday practice. They cover how to raise the weight conversation with and without a patient’s cue, which baseline labs to order, how to counsel patients on GLP-1 medications around pregnancy, and how to build a multidisciplinary team.
- Bone & Sports # 120Oct 27, 2026
Understanding Shoulder Embolization: Techniques & Patient Outcomes
For patients with frozen shoulder who have failed injections and months of physical therapy, can embolization offer relief when there are no good surgical options left? On this episode of the BackTable 2026 MSK Creator Weekend™, Dr. Anuj Malhotra of NYU Langone Hospital Long Island and Dr. Ahmed Farag of Advanced Vascular Institute in Panama City, Florida, join host Dr. Kavi Krishnasamy to examine shoulder embolization for adhesive capsulitis, osteoarthritis, and chronic rotator cuff tendinopathy. They cover the workup, how long to persist with conservative care, who makes the ideal candidate, and why the evidence outside adhesive capsulitis is still thin.
- Cardiology # 58Oct 27, 2026
Renal Denervation Explained: Procedure, Guidelines & Best Practices
Renal denervation is back in the guidelines, but what does the latest evidence mean for patient selection, technique, and counseling in the cath lab? On this episode of BackTable Cardiology, Dr. Vladimir Lakhter interviews Dr. Dmitriy Feldman, director of endovascular services in the Division of Cardiology at Weill Cornell Medicine, about where renal denervation fits in hypertension care today. They cover the new guideline recommendation, the history behind the procedure's comeback, the referral pathway and pre-procedural workup, and how to counsel patients on what to expect.
- ENT & Allergy # 300Oct 27, 2026
Surgical Management of Pediatric Invasive Fungal Sinusitis
What once meant a 3:00 AM trip to the operating room is now a planned daytime case: with antifungal pretreatment and a standardized protocol, one pediatric team in Memphis estimates survival of about 94 percent over 15 years for children with cancer and invasive fungal sinusitis (IFS), compared with published mortality estimates ranging from 20 to 80 percent. On this episode of the BackTable Creator Weekend™ series on pediatric head and neck cancer, host Dr. Javan Nation welcomes Dr. Rob Tuliszewski and Dr. Anthony Sheyn, pediatric otolaryngologists at Le Bonheur Children's Hospital and St. Jude Children's Research Hospital, to walk through the surgical management of invasive fungal sinusitis in children with cancer. They discuss pretransplant ENT screening, the inpatient consult, what early disease looks like on endoscopy, how antifungal pretreatment changes the urgency of surgery, and how they approach debridement in the operating room.
- CardioNerds # 471Oct 21, 2026
ACS Guidelines Question #9
This episode is part of our comprehensive Decipher the Guidelines Series covering the 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes. The following question refers to Section 9.2 of the 2025 ACS Guidelines. The question is asked by Johns Hopkins pre-medical undergraduate and CardioNerds Academy Intern Joshua Khorsandi, answered first by University of Wisconsin cardiology fellow and member of the CardioNerds Interventional Cardiology Council Dr. Shikha Jha, and then by expert faculty Dr. Venu Menon. Dr. Menon is the Section Head of Clinical Cardiology, Director of the Cardiac Intensive Care Unit, and Program Director of Cardiology Fellowship at the Cleveland Clinic. He is the Mehdi Razavi Endowed Chair and Professor of Medicine at the Cleveland Clinic Lerner College of Medicine. He was also a member of the 2025 ACS Guidelines writing committee.